|
|
Article: VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009.
- Article from:
- PR Newswire
- Article date:
- March 31, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Data from ACS Phase 2 MDCT Sub-study to be Released Concurrent with AHA Presentation
SAN FRANCISCO, March 31 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. , a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that an abstract on the Company's Phase 2 clinical trial of VIA-2291 has been accepted for a poster presentation at the American Heart Association Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009, taking place April 29 - May 1, 2009 in Washington, D.C. The presentation will summarize results of a sub-study of patients from the Company's ...